Average Co-Inventor Count = 5.94
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Institut National De La Sante Et De La Recherche Medicale (6 from 1,743 patents)
2. Aventis Pharma S.a. (6 from 377 patents)
3. Institut National Sante Et Recherche Medicale (1 from 1 patent)
4. Universitë De Bordeaux (203 patents)
5. Inserm (0 patent)
10 patents:
1. 10519503 - Diagnosis of hereditary spastic paraplegias (HSP) by detection of a mutation in the KIAA1840 gene or protein
2. 9546402 - Diagnosis of hereditary spastic paraplegias (HSP) by detection of a mutation in the KIAA1840 gene or protein
3. 9540693 - Mutations of the parkin gene, compositions, methods and uses
4. 9522933 - Diagnosis of hereditary spastic paraplegias (HSP) by identification of a mutation in the ZFYVE26 gene or protein
5. 8835618 - Mutations of the parkin gene
6. 8728727 - Diagnosis of hereditary spastic paraplegias (HSP) by detection of a mutation in the KIAA1840 gene or protein
7. 8273548 - Nucleic acids encoding a human PAP1 polypeptide
8. 7998667 - Mutations of the parkin gene, compositions, methods and uses
9. 7132396 - Compositions which can be used for regulating the activity of parkin
10. 7070940 - Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein